🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Single centre, open-label, single dose, parallel group study to investigate...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2020-07-07
Trial ID
NCT04449939
Treatments Being Tested
This is an investigator-initiated clinical trial evaluating the safety, tol...
Status
Active Not Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2024-12-30
Trial ID
NCT07461181
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of anti-OX40 ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-12-27
Trial ID
NCT03390296
The purpose of this study is to determine the safety and tolerability of ad...
Status
Completed
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02647866
This phase I trial studies the side effects of intratumoral injection of SD...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-03-13
Trial ID
NCT03831295
Treatments Being Tested
This study is a first-in-class open-label phase I human clinical study to e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06
Trial ID
NCT05788107
Treatments Being Tested
This is a multicenter, open-label, Phase 1 dose-escalation study of BAT6026...
Status
Terminated
Location
St George Private Hospital
Start Date
2022-02-28
Trial ID
NCT05109650
A Phase 2, multicenter, randomized, placebo-controlled, double-blind, paral...
Status
Completed
Location
Kyowa Investigational Site US-19
Start Date
2018-10-22
Trial ID
NCT03703102
This clinical trial will examine a novel combination of anti-OX40 to induce...
Status
Completed
Location
Providence Portland Medical Center
Start Date
2010-10-14
Trial ID
NCT01303705
Treatments Being Tested
The purpose of this study is to test the safety of the anti-OX40 antibody, ...
Status
Completed
Location
Portland Providence Medical Center
Start Date
2014-11-12
Trial ID
NCT02274155
Treatments Being Tested